Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update.


Journal

Heart failure clinics
ISSN: 1551-7136
Titre abrégé: Heart Fail Clin
Pays: United States
ID NLM: 101231934

Informations de publication

Date de publication:
Jul 2024
Historique:
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 6 6 2024
Statut: ppublish

Résumé

Hereditary transthyretin-related amyloidosis (hATTR) is the most common form of familial amyloidosis. It is an autosomal dominant disease caused by a pathogenic variant in the TTR gene. More than 140 TTR gene variants have been associated with hATTR, with the Val30Met variant representing the most common worldwide. The clinical phenotype varies according to the gene variant and includes predominantly cardiac, predominantly neurologic, and mixed phenotypes. The present review aims to describe the genotype-phenotype correlations in hATTR. Understanding these correlations is crucial to facilitate the early identification of the disease, predict adverse outcomes, and guide management with approved disease-modifying therapies.

Identifiants

pubmed: 38844302
pii: S1551-7136(24)00024-2
doi: 10.1016/j.hfc.2024.03.006
pii:
doi:

Substances chimiques

Prealbumin 0
TTR protein, human 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

317-323

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure G. Limongelli received an unrestricted research grant from Pfitzer. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.

Auteurs

Emanuele Monda (E)

Inherited and Rare Cardiovascular Disease Unit, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", AORN Dei Colli - Monaldi Hospital, Leonardo Bianchi Street, Naples 80100, Italy.

Chiara Cirillo (C)

Inherited and Rare Cardiovascular Disease Unit, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", AORN Dei Colli - Monaldi Hospital, Leonardo Bianchi Street, Naples 80100, Italy.

Federica Verrillo (F)

Inherited and Rare Cardiovascular Disease Unit, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", AORN Dei Colli - Monaldi Hospital, Leonardo Bianchi Street, Naples 80100, Italy.

Giuseppe Palmiero (G)

Inherited and Rare Cardiovascular Disease Unit, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", AORN Dei Colli - Monaldi Hospital, Leonardo Bianchi Street, Naples 80100, Italy.

Luigi Falco (L)

Inherited and Rare Cardiovascular Disease Unit, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", AORN Dei Colli - Monaldi Hospital, Leonardo Bianchi Street, Naples 80100, Italy.

Alberto Aimo (A)

Department of Cardiology, Fondazione Toscana Gabriele Monasterio, Interdisciplinary Center for Health Sciences, Scuola Superiore Sant'Anna, Piazza Martiri Della Libertà 33, Pisa 56127, Italy.

Michele Emdin (M)

Cardiovascular Diseases, Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Via S. Zeno 2, 56127, Pisa, Italy; Cardio-thoracic Department, Fondazione Toscana Gabriele Monasterio, Via G. Moruzzi 1, Pisa 56124, Italy.

Marco Merlo (M)

Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, Via P. Valdoni 7, Trieste 34100, Italy; European Reference Network for Rare Low Prevalence and Complex Diseases of the Heart-ERN GUARD Heart Via P. Valdoni 7 Trieste 34100, Italy.

Giuseppe Limongelli (G)

Inherited and Rare Cardiovascular Disease Unit, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", AORN Dei Colli - Monaldi Hospital, Leonardo Bianchi Street, Naples 80100, Italy. Electronic address: limongelligiuseppe@libero.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH